IDH1-MUTATED MALIGNANCIES
Clinical trials for IDH1-MUTATED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new IDH1-MUTATED MALIGNANCIES trials appear
Sign up with your email to follow new studies for IDH1-MUTATED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktails target tough blood cancers
Disease control Recruiting nowThis study is testing several combinations of targeted drugs for adults with relapsed or hard-to-treat blood cancers that have specific genetic mutations. The main goals are to see if these combinations are safe and if they can help put the cancer into remission. Participants wil…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cancer drug safety tested in patients with organ impairment
Disease control Recruiting nowThis early study aims to understand the safety and how the body processes the cancer drug ivosidenib in people with specific genetic mutations who also have liver or kidney problems. It will enroll about 30 adults with various cancers who have these organ impairments, comparing t…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE1 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC